Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
SQ
|
James Morgan Mc Kelvey Jr.
Director |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 84.71% |
$35,384,000
$88.46 p/Share
|
Sep 18
2018 |
FNKO
|
Russell Eugene Nickel
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 100.0% |
$818,400
$20.46 p/Share
|
Sep 18
2018 |
WMT
|
Alice L Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 600,000 Reduced 1.04% |
$57,222,002
$95.37 p/Share
|
Sep 18
2018 |
WMT
|
Jim C Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 600,000 Reduced 1.04% |
$57,222,002
$95.37 p/Share
|
Sep 18
2018 |
WMT
|
S Robson Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 600,000 Reduced 1.04% |
$57,222,002
$95.37 p/Share
|
Sep 18
2018 |
ZYME
|
Lilly & CO Eli
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 6,870 Reduced 0.18% |
$100,027
$14.56 p/Share
|
Sep 18
2018 |
NKE
|
Monique S. Matheson
EVP: CHRO |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 16.23% |
$1,445,000
$85.0 p/Share
|
Sep 18
2018 |
LOW
|
Marshall A Croom
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 15,735 Reduced 24.94% |
$1,803,860
$114.64 p/Share
|
Sep 18
2018 |
HNNA
|
Thomas L Seavey
Director |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.33% |
$2,994
$14.97 p/Share
|
Sep 18
2018 |
ABCP
|
Iszo Capital Management LP |
SELL
Open market or private sale
|
Indirect | 158,416 Reduced 1.53% |
$85,545
$0.54 p/Share
|
Sep 18
2018 |
COLD
|
Fortress Investment Group LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,235,529 Reduced 100.0% |
$170,324,359
$23.54 p/Share
|
Sep 18
2018 |
SRCH
|
Luxor Capital Group, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 80,456,578 Reduced 100.0% |
-
|
Sep 18
2018 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,500 Added 0.13% |
$14,805
$9.87 p/Share
|
Sep 18
2018 |
MCHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 8,493 Added 0.11% |
$23,526
$2.77 p/Share
|
Sep 18
2018 |
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 33,892 Added 0.28% |
$1,585,468
$46.78 p/Share
|
Sep 18
2018 |
NILE
|
Ault & Company, Inc. |
BUY
Open market or private purchase
|
Direct | 3,500 Added 3.63% |
$1,505
$0.43 p/Share
|
Sep 18
2018 |
PRNB
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect | 270,000 Added 9.32% |
$4,590,000
$17.0 p/Share
|
Sep 18
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 37,263 Added 0.19% |
$252,643
$6.78 p/Share
|
Sep 18
2018 |
ODTC
|
Tang Kevin C
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.08% |
$964,500
$19.29 p/Share
|
Sep 18
2018 |
IRIX
|
Paragon Associates & Paragon Associates Ii Joint Venture |
BUY
Open market or private purchase
|
Direct | 70,000 Added 5.04% |
$420,000
$6.0 p/Share
|
Sep 18
2018 |
PRNB
|
Orbimed Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 8.75% |
$4,250,000
$17.0 p/Share
|
Sep 18
2018 |
SRCH
|
Luxor Capital Group, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 80,456,578 Added 44.22% |
-
|
Sep 18
2018 |
BBQ
|
David Kanen
Director |
BUY
Open market or private purchase
|
Indirect | 600 Added 0.05% |
$3,864
$6.44 p/Share
|
Sep 18
2018 |
STON
|
Axar Capital Management L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 19,040 Added 0.14% |
$85,490
$4.49 p/Share
|
Sep 18
2018 |
HLI
|
Robert A Schriesheim
Director |
BUY
Open market or private purchase
|
Direct | 118 Added 0.57% |
$5,478
$46.42 p/Share
|
Sep 18
2018 |
BKGM
|
Guerrero Martin Dela Rosa Leon
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.11% |
$11,000
$11.0 p/Share
|
Sep 17
2018 |
BKGM
|
Patricia Ann Perez Ada
Director |
BUY
Open market or private purchase
|
Direct | 22 Added 0.04% |
$220
$10.0 p/Share
|
Sep 17
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 38,137 Added 0.2% |
$250,179
$6.56 p/Share
|
Sep 17
2018 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,790 Added 0.15% |
$16,450
$9.19 p/Share
|
Sep 17
2018 |
MCHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 900 Added 0.02% |
$2,430
$2.7 p/Share
|
Sep 17
2018 |
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 75,808 Added 0.62% |
$3,522,798
$46.47 p/Share
|
Sep 17
2018 |
IFF
|
Winder Investment Pte LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,272,160 Added 11.28% |
$295,948,840
$130.25 p/Share
|
Sep 17
2018 |
BBQ
|
David Kanen
Director |
BUY
Open market or private purchase
|
Indirect | 19,526 Added 1.58% |
$124,771
$6.39 p/Share
|
Sep 17
2018 |
STON
|
Axar Capital Management L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 6,420 Added 0.09% |
$27,863
$4.34 p/Share
|
Sep 17
2018 |
ROSE
|
K2 Principal Fund, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 12,868 Reduced 5.1% |
$105,775
$8.22 p/Share
|
Sep 17
2018 |
STR
|
Jana Partners LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 38,159 Reduced 1.16% |
$430,052
$11.27 p/Share
|
Sep 17
2018 |
ZYME
|
Lilly & CO Eli
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 6,865 Reduced 0.18% |
$100,092
$14.58 p/Share
|
Sep 17
2018 |
IRDM
|
S. Scott Smith
Director |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 1.58% |
$70,210
$20.06 p/Share
|
Sep 17
2018 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect | 7,360 Reduced 11.73% |
$516,525
$70.18 p/Share
|
Sep 17
2018 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 100.0% |
$7,018,000
$70.18 p/Share
|
Sep 17
2018 |
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 12.57% |
$185,325
$49.42 p/Share
|
Sep 17
2018 |
NEE
|
Joseph T Kelliher
EVP, Federal Reg. Affairs |
SELL
Open market or private sale
|
Direct | 8,035 Reduced 21.93% |
$1,392,466
$173.3 p/Share
|
Sep 17
2018 |
NEE
|
Paul I Cutler
Treasurer |
SELL
Open market or private sale
|
Direct | 7,639 Reduced 7.72% |
$1,323,839
$173.3 p/Share
|
Sep 17
2018 |
NCLH
|
Frank J Del Rio
Former Pres. & CEO |
SELL
Open market or private sale
|
Direct | 3,077 Reduced 0.99% |
$172,312
$56.0 p/Share
|
Sep 17
2018 |
SQ
|
Alyssa Henry
Square Lead |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 5.32% |
$2,228,000
$89.12 p/Share
|
Sep 17
2018 |
FNKO
|
Andrew Mark Perlmutter
Director |
SELL
Open market or private sale
|
Direct | 55,000 Reduced 100.0% |
$1,107,700
$20.14 p/Share
|
Sep 17
2018 |
EVBG
|
James Totton
EVP, Product Mgmt, Eng & Ops |
SELL
Open market or private sale
|
Direct | 14,199 Reduced 68.96% |
$845,976
$59.58 p/Share
|
Sep 17
2018 |
LLY
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 5.15% |
$316,830
$105.61 p/Share
|
Sep 17
2018 |
AVGO
|
Hock E Tan
President and CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 15.4% |
$4,776,000
$238.8 p/Share
|
Sep 17
2018 |
CSCO
|
Charles Robbins
Chair and CEO |
SELL
Open market or private sale
|
Direct | 217,420 Reduced 38.68% |
$10,279,617
$47.28 p/Share
|
Sep 17
2018 |